Treatment of scleroderma heart by D-penicillamine.

AUTOR(ES)

Muers, M

RESUMO

A case of severe diffuse systemic sclerosis with cardiomegaly and cardiac failure is described. Treatment with D-penicillamine caused a pronounced decrease in heart size, together with clinical improvement. The use of penicillamine in scleroderma heart has not previously been reported.

Documentos Relacionados

• Myelotoxicity of D-penicillamine.
• Cholestatic jaundice caused by D-penicillamine.
• Treatment of systemic sclerosis with D-penicillamine. A new method of observing the effects of treatment.
• Alclofenac and D-penicillamine. Comparative trial in rheumatoid arthritis.
• Thrombokinetics in patients with rheumatoid arthritis treated with D-penicillamine.